Migdal Insurance & Financial Holdings’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,099
Closed -$1.69M 752
2020
Q3
$1.69M Sell
6,099
-5,285
-46% -$1.52M 0.02% 212
2020
Q2
$2.75M Buy
11,384
+3,714
+48% +$746K 0.04% 157
2020
Q1
$1.11M Buy
7,670
+4,573
+148% +$759K 0.03% 165
2019
Q4
$528K Buy
3,097
+430
+16% +$79.7K 0.01% 291
2019
Q3
$474K Buy
2,667
+798
+43% +$172K 0.01% 332
2019
Q2
$487K Buy
1,869
+542
+41% +$144K 0.01% 313
2019
Q1
$379K Buy
1,327
+623
+88% +$207K 0.01% 336
2018
Q4
$229K Buy
704
+384
+120% +$133K 0.01% 357
2018
Q3
$144K Buy
320
+197
+160% +$77.7K ﹤0.01% 562
2018
Q2
$50K Buy
+123
New +$44.6K ﹤0.01% 647

Other funds holding ABMD

Migdal Insurance & Financial Holdings's ABMD Position: Q4 2020 in Review

Migdal Insurance & Financial Holdings sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 6,099 shares — an estimated $1.69M sold.

Migdal Insurance & Financial Holdings first reported a position in ABMD in Q2 2018 and held it in 10 quarters. The position peaked at $2.75M in Q2 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Migdal Insurance & Financial Holdings reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 6,099 Abiomed Inc shares in Q4 2020, an estimated $1.69M.
  • Migdal Insurance & Financial Holdings first reported a position in Abiomed Inc in Q2 2018 and held it in 10 quarters.
  • Migdal Insurance & Financial Holdings's Abiomed Inc position peaked at $2.75M in Q2 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.